Bio-Reference Laboratories Inc $31.39

down -0.54


31/7/2014 03:48 PM  |  NASDAQ : BRLI  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get BRLI Trend Analysis - it has outperformed the S&P 500 by 1%

Partner Headlines

  1. Morning Market Movers

    Benzinga
  2. Earnings Scheduled For June 5, 2014

    Benzinga
  3. 4 Attractive Small-Cap Growth + Value Stocks You Have Never Heard Of

    GuruFocus
  4. Medical Diagnostic Labs Facing Medicare Headwinds

    GuruFocus
  5. Myriad Stock Tumbles After Court Allows Rival To Sell

    IBD
  6. Earnings Scheduled For March 4, 2014

    Benzinga
  7. Historical Short Interest Of Stocks - New Feature Announcement

    GuruFocus
  8. Myriad Price Cut Reflects Changing Gene-Test Industry

    IBD
  9. Myriad Hit By Downgrades After Reimbursement Cut

    IBD
  10. Earnings Scheduled For December 19, 2013

    Benzinga
  11. Stocks With The Highest Short Interest - New Feature Announcement

    GuruFocus
  12. UPDATE: Bank of America Lowers PT on Bio-Reference Laboratories Following ...

    Benzinga
  13. Myriad Genetics Sued On Gene Patents; Stock Falls

    IBD
  14. Alere Financial Says Bio-Reference Laboratories' Reimbursement Volatility ...

    Benzinga
  15. Bio-Reference cuts outlook

    IBD
  16. Stocks Up Slightly In Late Trade; Pegasystems Climbs

    IBD
  17. Bio-Reference Labs Slashes Guidance; Stock Plunges

    IBD
  18. Morning Market Losers

    Benzinga
  19. Earnings Scheduled For August 29, 2013

    Benzinga
  20. BioReference Reports Purchase of Edge BioSystems' Service Business, No ...

    Benzinga
  21. Myriad Genetics Falls On Downgrade, Despite Q4 Beat

    IBD
  22. Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry ...

    Benzinga
  23. Bio-Reference Labs Offers Extremely Stable Earnings

    IBD
  24. Quest Diagnostics Overhaul Continues With Unit Sale

    IBD
  25. Quest Diagnostics Overhaul Continues With Unit Sale

    IBD
  26. BioReference Laboratories Inc. Reports Operating Results (10-K)

    GuruFocus
  27. Bio-Reference Labs, Inc. (BRLI) Sr. VP, Sec'y, Treasurer, CFO Sam Singer ...

    GuruFocus
  28. Buffett-Munger Model Portfolio Posts Fourth Solid Year, Hits Refresh for ...

    GuruFocus
  29. Bio-Reference meets on Sandy

    IBD
  30. Stocks Mixed As Rally Fades; Lululemon Bounces Back

    IBD
  31. Bio-Reference Earnings Meet Views Despite Hurricane

    IBD
  32. Earnings Scheduled For December 6, 2012

    Benzinga
  33. Buffett-Munger Strategy: What Worked? What Didn't

    GuruFocus
  34. Many Stocks Dip In Weak Trade Amid Market Correction

    IBD
  35. Bio-Reference Laboratories Inc Reports Operating Results (10-Q)

    GuruFocus
  36. Buffett-Munger Model Portfolio Gained 16.1% Year-to-Date

    GuruFocus
  37. Stocks Back Off, So Does Volume

    IBD
  38. Health Care Sector Wrap

    FoxBusiness
  39. Stocks Trim Losses After Sliding Further

    IBD
  40. Bio-Reference Shares Fall On Q3 Revenue Shortfall

    IBD
  41. Stocks Trim Losses After Sliding Further

    IBD
  42. First Solar, Sears Holdings Among Stocks Down on Above-average Volume Thursday

    FoxBusiness
  43. US Stock Futures Down; Jobless Claims Data In Focus

    Benzinga
  44. Earnings Scheduled For August 30, 2012

    Benzinga
  45. Stocks To Watch For August 30, 2012

    Benzinga
  46. Health Care Sector Wrap

    FoxBusiness
  47. Health Care Sector Wrap

    FoxBusiness
  48. Buffett-Munger Model Portfolio Continues Its Outperformance

    GuruFocus
  49. Several Medical Stocks Climb From Breakouts

    IBD
  50. Stocks Sink In Late Trading; Mellanox Reverses Lower

    IBD
Trading Center